Revolution Medicines (RVMDW) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.13
-1.01
-0.89
-0.77

Details

Expected EPS
-1.090662
Actual EPS
-1.13
Surprise EPS
-0.04
Surprise Percent
+3.61%

Description

Revolution Medicines (RVMDW) has reported earnings of -1.13 per share for Q2 2025.

0 Comments

Share your thoughts